TY - JOUR ID - 106444 TI - In silico analysis of Ta9 gene polymorphism in an Iranian Theileria annulata schizont-infected cell line S15 vaccine strain and native isolates JO - Archives of Razi Institute JA - ARI LA - en SN - 0365-3439 AU - Habibi, G. AD - Department of Parasite Vaccine Research and Production, Razi Vaccine and Serum Research Institute, Karaj, Iran Y1 - 2016 PY - 2016 VL - 71 IS - 2 SP - 71 EP - 80 KW - Antigen KW - Iran KW - Polymorphism KW - Ta9 KW - Theileria annulata KW - vaccine DO - 10.22034/ari.2016.106444 N2 - Bovine theileriosis is a tick-borne disease caused by obligate intracellular parasites related to the genus Theileria. Cellular immune responses protect cattle against pathogens through the activation of immune cells. Nowadays, live, attenuated vaccine of Theileria annulata (T. annulata) is being produced in Iran and is recommended for active cattle immunization. Detection of the immunogenic  antigens and epitopes recognized by CD8+ T Lymphocytes is vital for the development of recombinant and subunit vaccines. Herein, sequences of the genes encoding Ta9, which is an important antigenrecognized by bovine CD8+ T cells specific for T. annulata, in Iranian S15 vaccine strains, several Iranian isolates, as well as reference Ta9 DNA sequences registered in GeneBank were compared through polymerase chain reaction (PCR). The obtained data from DNA sequences were analyzed by using "Nucleotide", "Blast n", "BioEdit" and "IEDB" softwares. The results showed high level of variation in nucleotides and amino acids level. The observed polymorphism in Ta9 gene sequences of Iranian vaccine strains and some isolates from Iran demonstrated that this antigen contains polymorphic sequences and is active along with the specific major histocompatibility complex (MHC) of the host. Polymorphic sequences and specific epitopes of Ta9 gene for CD8+ T cell provides an explanation for incomplete protection observed after inoculation of heterologous parasites in vaccinated cattle. These results have important implications for the application of Ta9 antigen for developing novel subunit vaccines.   UR - https://archrazi.areeo.ac.ir/article_106444.html L1 - https://archrazi.areeo.ac.ir/article_106444_37f454deb67a8d952a692291fd592daf.pdf ER -